Synapse - Evan B Marzouk

Evan B Marzouk

Research Focus

Former Employee. MEDICINE; Research Stdy Asst II

Recent additions – View all

Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
Journal Article

Mehta-Shah, N.; Lunning, M. A.; Moskowitz, A. J.; Boruchov, A. M.; Ruan, J.; Lynch, P.; Hamlin, P. A.; Leonard, J.; Matasar, M. J.; Myskowski, P. L.; more...
American Journal of Hematology (2021)

Fulltext@MSK | Save
The combination of duvelisib, a PI3K-δ,γ inhibitor, and romidepsin is highly active in relapsed/refractory peripheral T-cell lymphoma with low rates of transaminitis: Results of parallel multicenter, phase 1 combination studies with expansion cohorts
Meeting Abstract

Horwitz, S. M.; Moskowitz, A. J.; Jacobsen, E. D.; Mehta-Shah, N.; Khodadoust, M. S.; Fisher, D. C.; Myskowski, P.; Wang, E. B. K.; Tawa, M.; Davey, T.; more...
Blood (2018)

Fulltext@MSK | Save
In vitro, in vivo, and parallel phase I evidence support the safety and activity of duvelisib, a PI3K-δ,γ inhibitor, in combination with romidepsin or bortezomib in relapsed/refractory T-cell lymphoma
Meeting Abstract

Moskowitz, A. J.; Koch, R.; Mehta-Shah, N.; Myskowski, P.; Kheterpal, M.; Dogan, A.; Davey, T.; Galasso, N.; Evan, M.; Shah, M.; more...
Blood (2017)

Fulltext@MSK | Save

Co-authors at MSK

3

Galasso
3

Ganesan
3

Horwitz
3

Moskowitz
3

Myskowski
2

Davey
2

Dogan
1

Bahgat
1

Blouin
1

Hamlin
1

Hancock
1

Kheterpal
1

Kumar
1

Lubin
1

Lunning
1

Lynch
1

Matasar
1

Minnal
1

Nair
1

Noy
1

Palomba
1

Rademaker
1

Schaffer
1

Schoder
1

Shah
1

Shah
1

Sholkla...
1

Straus
1

Zelenetz

Types of Work

Publications

Blood (2)
American Journal of Hematology (1)